Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Natansh D. Modi"'
Autor:
Sara A. Almansour, Mohammad A. Y. Alqudah, Ziad Abuhelwa, Humaid O. Al-Shamsi, Ahmad Alhuraiji, Mohammad H. Semreen, Yasser Bustanji, Karem H. Alzoubi, Natansh D. Modi, Ross A. Mckinnon, Michael J. Sorich, Ashley M. Hopkins, Ahmad Y. Abuhelwa
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Patients with multiple myeloma (MM) are at risk of venous thromboembolism (VTE), worsened by immunomodulatory drugs. Although antithrombotics are recommended for prophylaxis, existing guidelines are suboptimal and treatment outcomes remai
Externí odkaz:
https://doaj.org/article/574a46f0d0014af3ac9dee2e65e01aa8
Autor:
Natansh D. Modi, Ganessan Kichenadasse, Tammy C. Hoffmann, Mark Haseloff, Jessica M. Logan, Areti A. Veroniki, Rebecca L. Venchiarutti, Amelia K. Smit, Haitham Tuffaha, Harindra Jayasekara, Arkady Manning-Bennet, Erin Morton, Ross A. McKinnon, Andrew Rowland, Michael J. Sorich, Ashley M. Hopkins
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-9 (2023)
Abstract Data sharing is essential for promoting scientific discoveries and informed decision-making in clinical practice. In 2013, PhRMA/EFPIA recognised the importance of data sharing and supported initiatives to enhance clinical trial data transpa
Externí odkaz:
https://doaj.org/article/39006a458d8e4b17acbae61b21a5e80d
Autor:
Natansh D. Modi, Ahmad Y. Abuhelwa, Sarah Badaoui, Emily Shaw, Kiran Shankaran, Ross A. McKinnon, Andrew Rowland, Michael J. Sorich, Ashley M. Hopkins
Publikováno v:
Breast, Vol 58, Iss , Pp 57-62 (2021)
Introduction: Neutropenia and diarrhoea are common and potentially serious adverse events associated with abemaciclib in advanced breast cancer (ABC), and the risk factors have been minimally explored. The study aimed to develop clinical prediction t
Externí odkaz:
https://doaj.org/article/6d91179f0f1a4a5b94dd4acad5c443e9
Autor:
Natansh D. Modi, Jin Quan Eugene Tan, Andrew Rowland, Bogda Koczwara, Ahmad Y. Abuhelwa, Ganessan Kichenadasse, Ross A. McKinnon, Michael D. Wiese, Michael J. Sorich, Ashley M. Hopkins
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-6 (2021)
Abstract While many studies have evaluated the relationship between BMI and breast cancer outcomes, it is unclear whether this relationship is consistent between early breast cancer (BC) and advanced BC. The study included 5099 patients with HER2 pos
Externí odkaz:
https://doaj.org/article/24447a25e7ac4170bca7ea29c9ade681
Autor:
Natansh D. Modi, Ahmad Y. Abuhelwa, Bradley D. Menz, Ross A. McKinnon, Michael J. Sorich, Ashley M. Hopkins
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/e44f3e86e2164febad1075be2ea00d12
Autor:
Natansh D. Modi, Jin Quan Eugene Tan, Andrew Rowland, Bogda Koczwara, Ganessan Kichenadasse, Ross A. McKinnon, Michael D. Wiese, Michael J. Sorich, Ashley M. Hopkins
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Introduction: Beta-blockers (BB) are commonly used to manage cardiovascular disease and may have benefits in controlling complications of anti-HER2 therapies. This study aimed to evaluate the association of pre-existing BB use with survival outcomes
Externí odkaz:
https://doaj.org/article/0bcf400d16d3446a86b9c3c92a8f7068
Autor:
Kiran Shankaran, Ross A. McKinnon, Michael J. Sorich, Andrew Rowland, Sarah Badaoui, Natansh D. Modi, Ashley M. Hopkins, Emily Shaw, Ahmad Y. Abuhelwa
Publikováno v:
Breast, Vol 58, Iss, Pp 57-62 (2021)
The Breast : Official Journal of the European Society of Mastology
The Breast : Official Journal of the European Society of Mastology
Introduction Neutropenia and diarrhoea are common and potentially serious adverse events associated with abemaciclib in advanced breast cancer (ABC), and the risk factors have been minimally explored. The study aimed to develop clinical prediction to
Autor:
Ross A. McKinnon, Andrew Rowland, Ahmad Y. Abuhelwa, Natansh D. Modi, Ganessan Kichenadasse, Michael J. Sorich, Ashley M. Hopkins, Jin Quan Eugene Tan, Bogda Koczwara, Michael D. Wiese
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-6 (2021)
NPJ Breast Cancer
NPJ Breast Cancer
While many studies have evaluated the relationship between BMI and breast cancer outcomes, it is unclear whether this relationship is consistent between early breast cancer (BC) and advanced BC. The study included 5099 patients with HER2 positive ear
Autor:
Natansh D. Modi, Bogda Koczwara, Michael J. Sorich, Michael D. Wiese, Ross A. McKinnon, Andrew Rowland, Ashley M. Hopkins
Publikováno v:
Clinical Breast Cancer. 20:e220-e228
Introduction: Thrombocytopenia is a common and potentially serious adverse event of ado-trastuzumab emtansine (T-DM1) use in patients with advanced breast cancer. However, the risk factors have been minimally explored. Our aim was to develop a clinic
Autor:
Michael J. Sorich, Natansh D. Modi, Ross A. McKinnon, Ashley M. Hopkins, Fang L.I. Ang, Andrew Rowland
Publikováno v:
Journal of Cancer
Background: This study aimed to investigate the impact of early adverse events (AE) following the initiation of lapatinib plus capecitabine on the progression-free survival (PFS) and overall survival (OS) outcomes of human epidermal growth factor rec